Global Perfusion Systems Market, By Component (Heart-lung Machines, Perfusion Pumps, Oxygenators, Monitoring Systems, Cannulas), Type (Bioreactor Perfusion Systems, Microfluidic Perfusion Systems, Gravity Or Pressure-Driven Perfusion Systems, Small-Mammal Organ Perfusion Systems), Technique (Hypothermic Machine Perfusion, Normothermic Machine Perfusion)-Industry Trends and Forecast to 2029.
Global Perfusion Systems Market Analysis and Size
In order to treat patients with cardiac and respiratory disorders surgically, perfusion devices are employed to bypass cardiopulmonary systems. When the heart and lungs are unable to carry out the process of blood oxygenation, perfusion devices such as heart-lung machines give oxygen and remove carbon dioxide.
- Oxygenators accounts for the largest component segment in the perfusion systems market due to the growing prevalence of cardiopulmonary failure. Data Bridge Market Research analyses that the perfusion systems market was valued at USD 1,198.8 million in 2021 and is further estimated to reach USD 60.50 million by 2029, and is expected to grow at a CAGR of 4.4% and at a during the forecast period of 2022 to 2029.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Component (Heart-lung Machines, Perfusion Pumps, Oxygenators, Monitoring Systems, Cannulas), Type (Bioreactor Perfusion Systems, Microfluidic Perfusion Systems, Gravity Or Pressure-Driven Perfusion Systems, Small-Mammal Organ Perfusion Systems), Technique (Hypothermic Machine Perfusion, Normothermic Machine Perfusion)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Getinge AB (Sweden), Medtronic PLC (US), Livanova PLC (UK), Terumo Corporation (Japan), Nipro Corporation (Japan), Xenios AG (Germany), Repligen Corporation (US), Spectrum Laboratories, Inc. (US), Merck KGaA (Germany), Harvard Bioscience, Inc. (US), ALA Scientific Instruments, Inc. (US), Lifeline Scientific (US), Xvivo Perfusion AB (Sweden), General Electricals Inc (US), Hitachi Ltd (Japan), Koninkliijike Philips N.V. (Netherlands), Samsung Electronics Co, Ltd. (South Korea), Shimadzu Corporation (Japan), Siemens (US), Toshiba Corporation (Japan), Accuray Incorporated (US), Xvivo Perfusion (Sweden).
|
|
Market Opportunities
|
|
Global Perfusion Systems Market Definition
The process of providing oxygenated blood to the body's tissues is known as perfusion. Perfusion systems are commonly used in organ transplant surgeries because they assist in the replacement of the organ's function by pumping blood throughout the body.
Perfusion Systems Market Dynamics
Major factors that are expected to boost the growth of the perfusion systems market in the forecast period are as follows:
Drivers
-
Rise in the Incidence of Cardiovascular and Respiratory Diseases
Cardiovascular illnesses are one of the most common causes of death worldwide. They are responsible for over 9.4 million fatalities per year. Hypertension is becoming more common, which is a major risk factor for cardiovascular disease and stroke will further accelerate the market growth.
-
Growing Healthcare Expenditure
The market is growing due to an increase in the number of organ donors, increased healthcare spending, and favourable healthcare legislation.
-
Constant Product Advancement
In the coming years, the expanding number of system distributors and dealers is expected to strengthen market growth for perfusion systems.
Opportunities
In addition, the growing pharmaceutical research is further estimated to provide potential opportunities for the growth of the perfusion systems market in the coming years.
Restraints/Challenges Global Perfusion Systems Market
On the other hand, the increased cost of organ transplantation is further projected to impede the growth of the perfusion systems market in the targeted period. However, the organ supply-demand gap might further challenge the growth of the perfusion systems market in the near future.
This perfusion systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the perfusion systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Perfusion Systems Market
The pandemic of COVID-19 has had a huge impact on the perfusion systems market. The global COVID-19 outbreak has shifted financial resources away from healthcare and toward perfusion systems. COVID-19 also causes organ failure, making transplantation difficult. The COVID-19 outbreak has been rescheduled in most locations around the world to suit the situation and prevent patient exposure to the virus through perfusion systems. However, in the post-COVID scenario, perfusion systems market is projected to be significantly impacted.
Recent Development
- In May 2019, Xvivo Perfusion System received FDA approval for their Steen solution perfusate system. The device lets the transplant team to perform a careful assessment of lung function to get a healthier sense of how the organs are working when they are perfused with a solution outside the body to better conclude whether the lungs can then be workable for transplant.
Global Perfusion Systems Market Scope and Market Size
The perfusion systems market is segmented on the basis of component, type and technique. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Component
- Heart-lung Machines
- Perfusion Pumps
- Oxygenators
- Monitoring Systems
- Cannulas
On the basis of component, the perfusion systems market is segmented into heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas.
Type
- Bioreactor Perfusion Systems
- Microfluidic Perfusion Systems
- Gravity or Pressure-Driven Perfusion Systems
- Small-Mammal Organ Perfusion Systems
On the basis of type, the perfusion systems market is segmented into bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure-driven perfusion systems and small-mammal organ perfusion systems.
Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
On the basis of technique, the perfusion systems market is segmented into hypothermic machine perfusion, normothermic machine perfusion.
Perfusion Systems Market Regional Analysis/Insights
The perfusion systems market is analysed and market size insights and trends are provided by country, component, type and technique as referenced above.
The countries covered in the perfusion systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the perfusion systems market due to the rise in the demand for organ transplant and cardiothoracic surgeries. Furthermore, the several initiatives taken by the government to raise the awareness for organ donation will further boost the growth of the perfusion systems market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the perfusion systems market due to the rise in the adoption of advanced technologies. Moreover, the increasing population is further anticipated to propel the growth of the perfusion systems market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The perfusion systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for perfusion systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the perfusion systems market. The data is available for historic period 2010-2020.
Competitive Landscape and Perfusion Systems Market Share Analysis
The perfusion systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to perfusion systems market.
Some of the major players operating in the perfusion systems market are:
- Getinge AB (Sweden)
- Medtronic PLC (US)
- Livanova PLC (UK)
- Terumo Corporation (Japan)
- Nipro Corporation (Japan)
- Xenios AG (Germany)
- Repligen Corporation (US)
- Spectrum Laboratories, Inc. (US)
- Merck KGaA (Germany)
- Harvard Bioscience, Inc. (US)
- ALA Scientific Instruments, Inc. (US)
- Lifeline Scientific (US)
- Xvivo Perfusion AB (Sweden)
- General Electricals Inc (US)
- Hitachi Ltd (Japan)
- Koninkliijike Philips N.V. (Netherlands)
- Samsung Electronics Co, Ltd. (South Korea)
- Shimadzu Corporation (Japan)
- Siemens (US)
- Toshiba Corporation (Japan)
- Accuray Incorporated (US)
- Xvivo Perfusion (Sweden)
SKU-